1. Home
  2. CLLS vs MFIN Comparison

CLLS vs MFIN Comparison

Compare CLLS & MFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • MFIN
  • Stock Information
  • Founded
  • CLLS 1999
  • MFIN 1995
  • Country
  • CLLS France
  • MFIN United States
  • Employees
  • CLLS N/A
  • MFIN N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • MFIN Finance: Consumer Services
  • Sector
  • CLLS Health Care
  • MFIN Finance
  • Exchange
  • CLLS Nasdaq
  • MFIN Nasdaq
  • Market Cap
  • CLLS 299.0M
  • MFIN 243.9M
  • IPO Year
  • CLLS 2007
  • MFIN 1996
  • Fundamental
  • Price
  • CLLS $3.79
  • MFIN $9.79
  • Analyst Decision
  • CLLS Buy
  • MFIN Strong Buy
  • Analyst Count
  • CLLS 1
  • MFIN 1
  • Target Price
  • CLLS $4.00
  • MFIN $12.00
  • AVG Volume (30 Days)
  • CLLS 151.7K
  • MFIN 44.1K
  • Earning Date
  • CLLS 11-03-2025
  • MFIN 10-28-2025
  • Dividend Yield
  • CLLS N/A
  • MFIN 4.94%
  • EPS Growth
  • CLLS N/A
  • MFIN N/A
  • EPS
  • CLLS N/A
  • MFIN 1.75
  • Revenue
  • CLLS $63,438,000.00
  • MFIN $332,256,000.00
  • Revenue This Year
  • CLLS N/A
  • MFIN N/A
  • Revenue Next Year
  • CLLS $66.76
  • MFIN $1.53
  • P/E Ratio
  • CLLS N/A
  • MFIN $5.55
  • Revenue Growth
  • CLLS 223.09
  • MFIN 16.48
  • 52 Week Low
  • CLLS $1.10
  • MFIN $7.71
  • 52 Week High
  • CLLS $3.83
  • MFIN $10.98
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 65.98
  • MFIN 37.04
  • Support Level
  • CLLS $3.36
  • MFIN $9.81
  • Resistance Level
  • CLLS $3.60
  • MFIN $10.14
  • Average True Range (ATR)
  • CLLS 0.24
  • MFIN 0.29
  • MACD
  • CLLS 0.02
  • MFIN -0.09
  • Stochastic Oscillator
  • CLLS 96.95
  • MFIN 0.92

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About MFIN Medallion Financial Corp.

Medallion Financial Corp is a finance company that originates and services loans in various industries. The five operating segments are, (1) recreation, (2) home improvement, (3) commercial, (4) taxi medallion, and (5) strategic partnership loans. The company generates maximum revenue from the Recreation segment.

Share on Social Networks: